23 Fanconi Anemia Clinical Trials in New Haven, CT (2026)

Q: How do I join a clinical trial in New Haven?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you.

Recruiting Fanconi Anemia Studies in New Haven

NCT02493478Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Advanced airway interventions are common high risk, high stakes events for children in intensive care units (ICU) and emergency departments (ED), with risk for life and health threatening consequences...

New Haven, CT150,000 participantsChildren's Hospital of Philadelphia

View Study Details

NCT00063063Recruiting

Generic Database of Very Low Birth Weight Infants

The Generic Database (GDB) is a registry of very low birth weight infants born alive in NICHD Neonatal Research Network (NRN) centers. The GDB collects observational baseline data on both mothers and ...

New Haven, CT80,000 participantsNICHD Neonatal Research Network

View Study Details

NCT00009633Recruiting

Follow-up Visit of High Risk Infants

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, n...

New Haven, CT68,000 participantsNICHD Neonatal Research Network

View Study Details

NCT04237701Recruiting

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System....

New Haven, CT40,000 participantsYale University

View Study Details

NCT05838690Recruiting

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes amon...

New Haven, CT3,000 participantsChildren's Hospital of Philadelphia

View Study Details

NCT06526988Recruiting

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

An increasing number of guideline-directed medical therapies (GDMT) have been developed for patients with chronic heart failure with reduced ejection fraction (HFrEF). When used in combination at reco...

New Haven, CT2,200 participantsUniversity of Colorado, Denver

View Study Details

NCT05650658Recruiting

Left vs Left Randomized Clinical Trial

The investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failur...

New Haven, CT2,136 participantsBaylor College of Medicine

View Study Details

NCT04334707Recruiting

Kidney Precision Medicine Project

Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despit...

New Haven, CT1,000 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT04787042Recruiting

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

New Haven, CT316 participantsSimcha IL-18, Inc.

View Study Details

NCT06536296Recruiting

The Impact of Music Medicine on Preterm Brain Development and Behavior

The investigators are conducting a two-site randomized control trial with the aim of defining the impact of music (M) without or with parent voice (MPV) on very preterm infants' acute and cumulative s...

New Haven, CT243 participantsBrigham and Women's Hospital

View Study Details

NCT06950385Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

The main goal of this clinical trial is to learn if the drug eRapa works to slow down the progression of disease in patients diagnosed with Familial Adenomatous Polyposis (FAP). Researchers will compa...

New Haven, CT168 participantsRapamycin Holdings Inc.

View Study Details

NCT04862221Recruiting

TReatment for ImmUne Mediated PathopHysiology

TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will de...

New Haven, CT163 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT06588699Recruiting

Digoxin In NASH (CODIN)

Nonalcoholic steatohepatitis (NASH) is a severe subtype of nonalcoholic fatty liver disease (NAFLD) which affects 1 in 3 Americans. The mainstay of treatment for NASH, which was recently renamed metab...

New Haven, CT144 participantsYale University

View Study Details

NCT07273838Recruiting

Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome

The overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care in hospitalized patients with heart failure associated acute kidney injury is safe and effica...

New Haven, CT130 participantsYale University

View Study Details

NCT04551560Recruiting

Stress and Congestive Heart Failure

The purpose of this study is to investigate whether acute stress can precipitate congestive heart failure (CHF) exacerbation in patients with CHF....

New Haven, CT112 participantsYale University

View Study Details

NCT05323487Recruiting

Mechanisms of Diuretic Resistance in Heart Failure, Aim 1

This study will employ a randomized order, double-blind, repeated measures dose ranging design. This design was chosen in order to generate multiple within-subject serial loop diuretic dose response e...

New Haven, CT75 participantsYale University

View Study Details

NCT04438213Recruiting

Ertugliflozin in Chronic Heart Failure

The purpose of this study is to determine the effects on heart failure signs and symptoms of the use of either ertugliflozin, metolazone or placebo, in conjunction with intravenous loop diuretic use i...

New Haven, CT60 participantsYale University

View Study Details

NCT07457567Recruiting

Neural Mechanisms of the Social Brain

This study aims to understand the neural mechanisms that underlie synchronization of two brains during social interactions....

New Haven, CT50 participantsYale University

View Study Details

NCT05753059Recruiting

Mechanisms of Diuretic Resistance in Heart Failure, Aim 2

Randomized placebo-controlled, double-blind, double-dummy, crossover design testing combinations placebo/placebo, bendroflumethiazide/placebo, amiloride/placebo, and bendroflumethiazide/amiloride adde...

New Haven, CT50 participantsYale University

View Study Details

NCT06209359Recruiting

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Randomized double-blind placebo-controlled crossover study design...

New Haven, CT50 participantsYale University

View Study Details

NCT06671015Recruiting

A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure

This prospective, open-label randomized controlled pilot trial will enroll participants at the Yale New Haven Hospital. Patients with systolic heart failure, defined as an ejection fraction ≤40%, who ...

New Haven, CT50 participantsYale University

View Study Details

NCT07281014Recruiting

Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing

The purpose of this research study is to understand the biology related to the potential shortcomings of existing anti-aldosterone therapy....

New Haven, CT20 participantsYale University

View Study Details

NCT06872645Recruiting

Exploring Water-free Sodium Storage

The overarching goal of this proposal is to definitively establish if acute water free Na storage and release occurs, if the amount stored/released is of a quantity that is physiologically relevant, a...

New Haven, CT10 participantsYale University

View Study Details

About Fanconi Anemia Clinical Trials in New Haven

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 23 fanconi anemia clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 347,977 participants. Research is being sponsored by Children's Hospital of Philadelphia, NICHD Neonatal Research Network, Yale University and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in New Haven — FAQ

Are there fanconi anemia clinical trials in New Haven?

Yes, there are 23 fanconi anemia clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 23 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov